Summary

A specific antiserum to pure human amniotic fluid metalloproteinase inhibitor (TIMP) was raised in a sheep. This antiserum was used to demonstrate: firstly, the immunological identity of the TIMP activities from amniotic fluid and culture medium of human foetal lung fibroblasts; and secondly, by indirect immunofluorescence, the secretion of TIMP by human foetal lung fibroblasts, chondrocytes, epithelial cells and smooth muscle cells. The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate, was used to stimulate secretion of TIMP by human foetal lung fibroblasts and the ionophore monensin was used to demonstrate intracellular accumulation of TIMP in the Golgi apparatus of these cells. These results are discussed in relation to other inhibitors of collagenase reported in the literature, which are probably identical to TIMP.

Similar articles

Other journals from The Company of Biologists

Our resident columnist, Mole, uses Star Wars to illuminate why graduate students feel their future looks like a storm complete with sideways rain, and how to be good mentor rather than an agent of the Dark Side.

iPSCs may be a new source for obtaining HSCs. In their review, Fabiola A. de Castro and colleagues discuss the challenges involved in reprogramming, and the role of microRNAs in iPSC generation and HSC differentiation.

“…one of the best parts of this job: people from different places working together for a common goal.”

Susana and her research group at the Barts Cancer Institute, Queen Mary University of London, investigate how tumour progression is affected by the presence of extra centrosomes in a cancer cell, and how these cancer cells employ mechanisms to adapt to supernumerary centrosomes. She shares her thoughts on the broader impact of her research and the challenges of starting a new lab.